Zobrazeno 1 - 10
of 74
pro vyhledávání: '"JM Taymans"'
Autor:
I Coku, E Mutez, S Eddarkaoui, S Carrier, A Marchand, C Deldycke, L Goveas, G Baille, M Tir, R Magnez, X Thuru, G Vermeersch, W Vandenberghe, L Buée, L Defebvre, B Sablonnière, MC Chartier-Harlin, JM Taymans, V Huin
Publikováno v:
Movement Disorders
Movement Disorders, 2022, ⟨10.1002/mds.29124⟩
MOVEMENT DISORDERS
Movement Disorders, 2022, ⟨10.1002/mds.29124⟩
MOVEMENT DISORDERS
BackgroundPathogenic variants in the LRRK2 gene are a common monogenic cause of Parkinson’s disease. However, only seven variants have been confirmed to be pathogenic.ObjectivesWe identified two novel LRRK2 variants (H230R and A1440P) and performed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b0ae78928fa22e8fe8fbc5ba159e216
https://lirias.kuleuven.be/handle/20.500.12942/703885
https://lirias.kuleuven.be/handle/20.500.12942/703885
Autor:
Iannotta L; Department of Biology, University of Padova, Padova, PD, Italy.; National Research Council, c/o Humanitas Research Hospital, Institute of Neuroscience, Rozzano, Italy., Fasiczka R; Department of Anesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USA., Favetta G; Department of Biology, University of Padova, Padova, PD, Italy., Zhao Y; University College London, School of Pharmacy, London, UK., Giusto E; IRCCS San Camillo Hospital, Venice, Italy., Dall'Ara E; Department of Biology, University of Padova, Padova, PD, Italy.; Department of Cell Biochemistry, University of Groningen, Groningen, Netherlands., Wei J; Department of Biomedical Science, Florida Atlantic University, Boca Raton, FL, USA., Ho FY; Department of Cell Biochemistry, University of Groningen, Groningen, Netherlands., Ciriani C; Department of Biology, University of Padova, Padova, PD, Italy., Cogo S; Department of Biology, University of Padova, Padova, PD, Italy.; School of Biological Sciences, University of Reading, Reading, UK., Tessari I; Department of Biology, University of Padova, Padova, PD, Italy., Iaccarino C; Department of Biomedical Sciences, University of Sassari, Sassari, Italy., Liberelle M; Université de Lille, INSERM, CHU Lille, LilNCog - Lille Neuroscience & Cognition, Lille, France., Bubacco L; Department of Biology, University of Padova, Padova, PD, Italy.; Centro Studi per la Neurodegenerazione (CESNE), University of Padova, Padova, Italy., Taymans JM; Université de Lille, INSERM, CHU Lille, LilNCog - Lille Neuroscience & Cognition, Lille, France., Manzoni C; University College London, School of Pharmacy, London, UK., Kortholt A; Department of Cell Biochemistry, University of Groningen, Groningen, Netherlands., Civiero L; Department of Biology, University of Padova, Padova, PD, Italy.; IRCCS San Camillo Hospital, Venice, Italy., Hilfiker S; Department of Anesthesiology, Rutgers New Jersey Medical School, Newark, NJ, USA. sn656@njms.rutgers.edu., Lu ML; Department of Biomedical Science, Florida Atlantic University, Boca Raton, FL, USA. MLU3@health.fau.edu., Greggio E; Department of Biology, University of Padova, Padova, PD, Italy. elisa.greggio@unipd.it.; Centro Studi per la Neurodegenerazione (CESNE), University of Padova, Padova, Italy. elisa.greggio@unipd.it.
Publikováno v:
Cell death & disease [Cell Death Dis] 2024 Oct 17; Vol. 15 (10), pp. 752. Date of Electronic Publication: 2024 Oct 17.
Autor:
Morez M; University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Lara Ordóñez AJ; University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Melnyk P; University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Liberelle M; University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Lebègue N; University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Taymans JM; University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
Publikováno v:
Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2024 Sep; Vol. 34 (9), pp. 773-788. Date of Electronic Publication: 2024 Jul 19.
Autor:
Taymans JM; University of Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Yilmazer-Hanke D; Clinical Neuroanatomy, Neurology, University Hospital Ulm, University of Ulm, Ulm, Germany.
Publikováno v:
Frontiers in molecular neuroscience [Front Mol Neurosci] 2024 Aug 29; Vol. 17, pp. 1479278. Date of Electronic Publication: 2024 Aug 29 (Print Publication: 2024).
Autor:
Hernandez CC; Life Sciences Institute, University of Michigan, Ann Arbor, MI, United States., Gimenez LE; Life Sciences Institute, University of Michigan, Ann Arbor, MI, United States., Strassmaier T; Nanion Technologies Inc., Livingston, NJ, United States., Rogers M; Albion Drug Discovery Services Ltd., Cambridge, United Kingdom., Taymans JM; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
Publikováno v:
Frontiers in molecular neuroscience [Front Mol Neurosci] 2024 May 31; Vol. 17, pp. 1414816. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).
Autor:
Naaldijk Y; Department. of Anesthesiology and Department. of Physiology, Pharmacology and Neuroscience, Rutgers New Jersey Medical School, Newark, NJ, 07103, USA., Fernández B; Institute of Parasitology and Biomedicine ´López-Neyra¨, Consejo Superior de Investigaciones Científicas (CSIC), 18016, Granada, Spain., Fasiczka R; Department. of Anesthesiology and Department. of Physiology, Pharmacology and Neuroscience, Rutgers New Jersey Medical School, Newark, NJ, 07103, USA., Fdez E; Institute of Parasitology and Biomedicine ´López-Neyra¨, Consejo Superior de Investigaciones Científicas (CSIC), 18016, Granada, Spain., Leghay C; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Croitoru I; Biodonostia Health Research Institute (IIS Biodonostia), San Sebastain, Spain., Kwok JB; School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia., Boulesnane Y; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Vizeneux A; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Mutez E; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Calvez C; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Destée A; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Taymans JM; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Aragon AV; Donostia University Hospital, San Sebastian, Spain., Yarza AB; Biodonostia Health Research Institute (IIS Biodonostia), San Sebastain, Spain.; Donostia University Hospital, San Sebastian, Spain., Padmanabhan S; The Michael J. Fox Foundation for Parkinson´s Research, New York, NY, USA., Delgado M; Institute of Parasitology and Biomedicine ´López-Neyra¨, Consejo Superior de Investigaciones Científicas (CSIC), 18016, Granada, Spain., Alcalay RN; Department. of Neurology, Colsumbia University Medical Center, New York, NY, USA.; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Chatterton Z; School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia., Dzamko N; School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia., Halliday G; School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia., Ruiz-Martínez J; Biodonostia Health Research Institute (IIS Biodonostia), San Sebastain, Spain.; Donostia University Hospital, San Sebastian, Spain., Chartier-Harlin MC; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Hilfiker S; Department. of Anesthesiology and Department. of Physiology, Pharmacology and Neuroscience, Rutgers New Jersey Medical School, Newark, NJ, 07103, USA. sabine.hilfiker@rutgers.edu.
Publikováno v:
NPJ Parkinson's disease [NPJ Parkinsons Dis] 2024 Jan 08; Vol. 10 (1), pp. 12. Date of Electronic Publication: 2024 Jan 08.
Autor:
Iannotta L; Department of Biology, University of Padova, Padua, Italy.; National Research Council, c/o Humanitas Research Hospital, Institute of Neuroscience, Rozzano, Italy., Emanuele M; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Favetta G; Department of Biology, University of Padova, Padua, Italy., Tombesi G; Department of Biology, University of Padova, Padua, Italy.; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States., Vandewynckel L; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Lara Ordóñez AJ; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Saliou JM; University of Lille, CNRS, Inserm, CHU Lille, Institute Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, France., Drouyer M; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Sibran W; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Civiero L; Department of Biology, University of Padova, Padua, Italy.; IRCSS, San Camillo Hospital, Venice, Italy., Nichols RJ; Department of Pathology, Stanford University, Stanford, CA, United States., Athanasopoulos PS; Department of Cell Biochemistry, University of Groningen, Groningen, Netherlands., Kortholt A; Department of Cell Biochemistry, University of Groningen, Groningen, Netherlands.; YETEM-Innovative Technologies Application and Research Centre, Suleyman Demirel University West Campus, Isparta, Turkey., Chartier-Harlin MC; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France., Greggio E; Department of Biology, University of Padova, Padua, Italy.; Centro Studi per la Neurodegenerazione (CESNE), University of Padova, Padua, Italy., Taymans JM; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
Publikováno v:
Frontiers in molecular neuroscience [Front Mol Neurosci] 2023 Dec 18; Vol. 16, pp. 1269387. Date of Electronic Publication: 2023 Dec 18 (Print Publication: 2023).
Autor:
Taymans JM; Univ. Lille, Inserm, CHU Lille, UMR-S 1172-LilNCog-Lille Neuroscience & Cognition, F-59000, Lille, France. jean-marc.taymans@inserm.fr., Fell M; Merck & Co., Inc., 33 Avenue Louis Pasteur, Boston, MA, 02115, USA., Greenamyre T; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, 3501 Fifth Avenue, Suite 7039, Pittsburgh, PA, 15260, USA., Hirst WD; Neurodegenerative Diseases Research Unit, Biogen, 115 Broadway, Cambridge, MA, 02142, USA., Mamais A; Center for Translational Research in Neurodegenerative Disease, Department of Neurology, University of Florida, Gainesville, FL, USA., Padmanabhan S; The Michael J. Fox Foundation for Parkinson's Research, Grand Central Station, P.O. Box 4777, New York, NY, 10120, USA., Peter I; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, New York, NY, 10029, USA., Rideout H; Centre for Clinical, Experimental Surgery, and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece., Thaler A; Movement Disorders Unit and Laboratory of Early Markers of Neurodegeneration, Neurological Institute, Tel-Aviv Medical Center, Faculty of medicine, Tel-Aviv University, Tel-Aviv, Israel.
Publikováno v:
NPJ Parkinson's disease [NPJ Parkinsons Dis] 2023 Jul 01; Vol. 9 (1), pp. 104. Date of Electronic Publication: 2023 Jul 01.
Autor:
Filippini F; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France., Nola S; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France., Zahraoui A; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France., Roger K; Université Paris Cité, Proteomics Platform Necker, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, 75015 Paris, France., Esmaili M; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Sun J; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Wojnacki J; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France., Vlieghe A; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France., Bun P; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, NeurImag Imaging Facility, 75014 Paris, France., Blanchon S; Hybrigenics Services, 91000 Évry-Courcouronnes, France., Rain JC; Hybrigenics Services, 91000 Évry-Courcouronnes, France., Taymans JM; Université de Lille, INSERM, CHU Lille, UMR-S1172, LilNCog - Lille Neuroscience & Cognition, Lille, France., Chartier-Harlin MC; Université de Lille, INSERM, CHU Lille, UMR-S1172, LilNCog - Lille Neuroscience & Cognition, Lille, France., Guerrera C; Université Paris Cité, Proteomics Platform Necker, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, 75015 Paris, France., Galli T; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France; GHU Paris Psychiatrie & Neurosciences, Paris, France. Electronic address: thierry.galli@inserm.fr.
Publikováno v:
Cell reports [Cell Rep] 2023 Mar 28; Vol. 42 (3), pp. 112221. Date of Electronic Publication: 2023 Mar 10.
Autor:
Taymans JM; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France. jean-marc.taymans@inserm.fr., Mutez E; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.; CHU Lille, Movement Disorders Unit, F-59000, Lille, France., Sibran W; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Vandewynckel L; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Deldycke C; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Bleuse S; CHU Lille, Movement Disorders Unit, F-59000, Lille, France., Marchand A; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Sarchione A; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Leghay C; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Kreisler A; CHU Lille, Movement Disorders Unit, F-59000, Lille, France., Simonin C; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.; CHU Lille, Movement Disorders Unit, F-59000, Lille, France., Koprich J; Atuka Inc., Toronto, ON, Canada., Baille G; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France., Defebvre L; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.; CHU Lille, Movement Disorders Unit, F-59000, Lille, France., Dujardin K; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.; CHU Lille, Movement Disorders Unit, F-59000, Lille, France., Destée A; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.; CHU Lille, Movement Disorders Unit, F-59000, Lille, France., Chartier-Harlin MC; Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France. marie-christine.chartier-harlin@inserm.fr.
Publikováno v:
NPJ Parkinson's disease [NPJ Parkinsons Dis] 2023 Feb 07; Vol. 9 (1), pp. 21. Date of Electronic Publication: 2023 Feb 07.